España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Aurinia Pharmaceuticals
AUPH
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$8.77
0.53
6.43%
At close: -
$8.77
0
0.00%
After Hours: 7:59 PM EDT
Get Report
Comment
Aurinia Pharmaceuticals (AUPH) Forecast
News
Earnings
Aurinia Pharmaceuticals (AUPH) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
Aurinia Presents Data Underscoring Critical I...
Benzinga Newsdesk
Thursday, November 07, 2024
Aurinia Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
Aurinia Is Implementing A Strategic Restructu...
Benzinga Newsdesk
Aurinia Pharmaceuticals Q3 2024 Adj EPS $0.10...
Benzinga Newsdesk
Friday, October 11, 2024
Aurinia To Present Six Abstracts, Including F...
Benzinga Newsdesk
Tuesday, September 24, 2024
Aurinia Announces Japan Approval Of LUPKYNIS ...
Benzinga Newsdesk
Monday, September 16, 2024
Cantor Fitzgerald Reiterates Overweight on Au...
Benzinga Newsdesk
Thursday, September 12, 2024
Aurinia Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
Aurinia Pharmaceuticals Restructures Board Of...
Benzinga Newsdesk
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Au...
Benzinga Newsdesk
Friday, September 06, 2024
HC Wainwright & Co. Reiterates Buy on Aurinia...
Benzinga Newsdesk
Thursday, August 01, 2024
Aurinia Pharmaceuticals Narrows 2024 Net Prod...
Benzinga Newsdesk
Aurinia Pharmaceuticals Q2 2024 GAAP EPS $0.0...
Benzinga Newsdesk
Friday, June 07, 2024
ILJIN SNT Co., Ltd Announces Intention To Vot...
Benzinga Newsdesk
Wednesday, June 05, 2024
Aurinia Pharmaceuticals Announced An Oral Pre...
Benzinga Newsdesk
Tuesday, June 04, 2024
Aurinia Issues Letter To Shareholders In Resp...
Benzinga Newsdesk
Monday, June 03, 2024
Aurinia Pharmaceuticals Shareholder Urges Fel...
Benzinga Newsdesk
Tuesday, May 14, 2024
Analysis Showing LUPKYNIS Is A Cost-Effective...
Benzinga Newsdesk
Thursday, May 09, 2024
Aurinia Reports Presentation Of Two Studies A...
Benzinga Newsdesk
Tuesday, May 07, 2024
Aurinia Pharmaceuticals Shareholder Urges Boa...
Benzinga Newsdesk
Thursday, May 02, 2024
Aurinia Reiterates 2024 Net Product Revenue G...
Benzinga Newsdesk
Aurinia Pharmaceuticals Q1 2024 GAAP EPS $(0....
Benzinga Newsdesk
Wednesday, May 01, 2024
Aurinia Pharmaceuticals Announced Several Ini...
Benzinga Newsdesk
Tuesday, April 30, 2024
FDA Approves Updated LUPKYNIS (voclosporin) L...
Benzinga Newsdesk
Friday, March 01, 2024
HC Wainwright & Co. Reiterates Buy on Aurinia...
Benzinga Newsdesk
Thursday, February 29, 2024
Aurinia Receives Exemptive Relief from Canadi...
Benzinga Newsdesk
Friday, February 23, 2024
Cantor Fitzgerald Maintains Overweight on Aur...
Benzinga Newsdesk
Thursday, February 22, 2024
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Aurinia ...
Benzinga Newsdesk
Friday, February 16, 2024
RBC Capital Maintains Outperform on Aurinia P...
Benzinga Newsdesk
Thursday, February 15, 2024
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Aurinia Pharmaceuticals shares are trading lo...
Benzinga Newsdesk
Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buyback
Vandana Singh
Aurinia Pharmaceuticals Initiates Share Repur...
Benzinga Newsdesk
Aurinia Pharmaceuticals Reaffirms 2024 Revenu...
Benzinga Newsdesk
Aurinia Pharmaceuticals Q4 2023 GAAP EPS $(0....
Benzinga Newsdesk
Earnings Scheduled For February 15, 2024
Benzinga Insights
Reuters Reported Aurinia Finds No Buyer, To A...
Charles Gross
Wednesday, February 14, 2024
Earnings Outlook For Aurinia Pharmaceuticals
Benzinga Insights
Friday, January 05, 2024
What's Going On With Aurinia Pharmaceuticals Stock?
Erica Kollmann
Aurinia Pharmaceuticals Reports Preliminary U...
Benzinga Newsdesk
Wednesday, December 20, 2023
Aurinia Pharmaceuticals Has Submitted Its Inv...
Benzinga Newsdesk
Tuesday, November 21, 2023
Watching Aurinia Pharmaceuticals; Traders Cir...
Benzinga Newsdesk
Monday, November 20, 2023
What's Going On With Aurinia Pharmaceuticals Stock?
Adam Eckert
Monday, November 13, 2023
Aurinia Pharmaceuticals Announces Collaborati...
Benzinga Newsdesk
Tuesday, November 07, 2023
Aurinia Presents Breadth Of Data From AURORA ...
Benzinga Newsdesk
Thursday, November 02, 2023
Aurinia Presents Breadth Of Data At ASN 2023 ...
Benzinga Newsdesk
Aurinia Pharmaceuticals Had Cash, Cash Equiva...
Benzinga Newsdesk
Aurinia Pharmaceuticals Narrows FY23 Lupkynis...
Benzinga Newsdesk
Aurinia Pharmaceuticals Q3 EPS $(0.09) Beats ...
Benzinga Newsdesk
Show More